CHGA and small cell lung carcinoma: The SSHN signature begins to address this need, e.g., distinguishing SCLC that stain negative for neuroendocrine markers such as synaptophysin and chromogranin A (~25%) [25,32] from NSCLC, and mixed SCLC-NSCLC from NSCLC.